Results 191 to 200 of about 6,817,458 (407)

Smart Magnetic Nanocarriers for Multi-Stimuli On-Demand Drug Delivery [PDF]

, 2022
Parisa Eslami, Martin Albino, Francesca Scavone, Emo Chiellini, Andrea Morelli, Giovanni Baldi, Laura Cappiello, Saer Doumett, Giada Lorenzi, Costanza Ravagli, Andréa Caneschi, Anna Laurenzana, Claudio Sangregorio   +12 more
openalex   +1 more source

Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4/MOG‐IgG Dual Seropositive: A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune neuroinflammatory disease, typically characterized by antibodies against aquaporin 4 (AQP4‐IgG) or myelin oligodendrocyte glycoprotein (MOG‐IgG). Simultaneous seropositivity for both antibodies in a single patient is exceedingly rare.
Yeting Luo, Shuhua Xie, Xianghong Liu
wiley   +1 more source

Bioeliminable Nanohydrogels for Drug Delivery

, 2008
De Gao, Hao Xu, Martin A. Philbert, Raoul Kopelman   +3 more
openalex   +2 more sources

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Drug delivery across length scales

, 2018
Derfogail Delcassian, Asha K. Patel, Abel B. Cortinas, Róbert Langer   +3 more
openalex   +2 more sources

THERAPEUTIC APPLICATION FOR DRUG DELIVERY USING NEW BIOMIMETIC POLYMERSOMES

, 2022
Reeta. M Shalini. K
openalex   +2 more sources

A Novel Computational Approach for the Discovery of Drug Delivery System Candidates for COVID-19 [PDF]

, 2021
Taeheum Cho, Hyo-Sang Han, Junhyuk Jeong, Eun‐Mi Park, Kyu-Sik Shim   +4 more
openalex   +1 more source

Targeted drug delivery strategies for precision medicines

Nature Reviews Materials, 2021
Mandana T. Manzari, Yosi Shamay, Hiroto Kiguchi, N. Rosen, M. Scaltriti, D. Heller   +5 more
semanticscholar   +1 more source

Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones, Samuele Bonomi, Keith E. Stockerl‐Goldstein, Randall J. Bateman   +3 more
wiley   +1 more source

Nanoparticle-Mediated Drug Delivery of Doxorubicin Induces a Differentiated Clonogenic Inactivation in 3D Tumor Spheroids In Vitro [PDF]

, 2023
Roxana Cristina Popescu, Verena Kopatz, Ecaterina Andronescu, Diana Savu, W. Doerr   +4 more
openalex   +1 more source